Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S-W Kim

Showing results (771-780 of 806) with videos related to

Pageof 81
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 12, 2017
Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosisD Y Lee, J H Jee, Y Y Cho, et al.
Cell Death and Differentiation|March 19, 2016
PPARγ neddylation essential for adipogenesis is a potential target for treating obesityH-S Park, U-I Ju, J-W Park, et al.
Digestive Diseases and Sciences|February 22, 2002
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damageK W Choi, Y C Lee, I S Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancerY J Kim, S-A Im, H G Kim, et al.
Bone Marrow Transplantation|April 20, 2004
A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in JapanO Imataki, M Kami, S-W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2013
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancerJ-M Sun, Y C Ahn, E K Choi, et al.
Bone Marrow Transplantation|November 18, 2008
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined studyS-W Kim, S-i Mori, R Tanosaki, et al.
International Journal of Clinical Practice|January 23, 2014
Predictors of uropathogens other than Escherichia coli in patients with community-onset acute pyelonephritisY M Wi, S-W Kim, H-H Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†G R Blumenschein, E F Smit, D Planchard, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 25, 2011
A novel PRKAR1A mutation in Korean Carney complex familyS Y Rhee, H S Kwon, J H Lee, et al.
Pageof 81

Showing results (771-780 of 806) with videos related to

Sort By:
Pageof 81
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 12, 2017
Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosisD Y Lee, J H Jee, Y Y Cho, et al.
Cell Death and Differentiation|March 19, 2016
PPARγ neddylation essential for adipogenesis is a potential target for treating obesityH-S Park, U-I Ju, J-W Park, et al.
Digestive Diseases and Sciences|February 22, 2002
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damageK W Choi, Y C Lee, I S Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancerY J Kim, S-A Im, H G Kim, et al.
Bone Marrow Transplantation|April 20, 2004
A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in JapanO Imataki, M Kami, S-W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2013
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancerJ-M Sun, Y C Ahn, E K Choi, et al.
Bone Marrow Transplantation|November 18, 2008
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined studyS-W Kim, S-i Mori, R Tanosaki, et al.
International Journal of Clinical Practice|January 23, 2014
Predictors of uropathogens other than Escherichia coli in patients with community-onset acute pyelonephritisY M Wi, S-W Kim, H-H Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†G R Blumenschein, E F Smit, D Planchard, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 25, 2011
A novel PRKAR1A mutation in Korean Carney complex familyS Y Rhee, H S Kwon, J H Lee, et al.
Pageof 81